Research Paper Volume 15, Issue 24 pp 15134—15160
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer
Figure 7. COL10A1 mutation status according to the cBioPortal database. COL10A1 mutation frequency in pan-cancer examined by the cBioPortal database (A). COL10A1 mutation level in pan-cancer examined by the cBioPortal database (B). Mutation diagram of COL10A1 in pan-cancer was examined by the cBioPortal database (C).